EYPT FY 2022 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

EYPTEyePoint Pharmaceuticals, Inc.

$1B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$41M+12.1% YoY

Gross Profit

$33M79.9% margin

Operating Income

-$100M-240.6% margin

Net Income

-$102M-247.0% margin

EPS (Diluted)

$-2.74

Cash Flow

Operating Cash Flow

-$65M

Free Cash Flow

-$67M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$180M

Total Liabilities

$84M

Stockholders' Equity

$96M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$37M	+12.1%
Gross Profit	$33M	$29M	+15.0%
Operating Income	-$100M	-$55M	-80.3%
Net Income	-$102M	-$58M	-75.0%